CG
RGEN icon

Caprock Group’s Repligen RGEN Stock Holding History

Caprock Group’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,120
Closed -$297K – 643
2021
Q4 		$297K Sell
1,120
-164
-13% -$44.2K 0.02% 431
2021
Q3 		$371K Hold
1,284
– – 0.03% 325
2021
Q2 		$256K Buy
1,284
+1
+0.1% +$194 0.02% 420
2021
Q1 		$249K Sell
1,283
-23
-2% -$4.72K 0.03% 397
2020
Q4 		$250K Sell
1,306
-1,078
-45% -$196K 0.03% 377
2020
Q3 		$352K Buy
2,384
+80
+3% +$11.4K 0.05% 262
2020
Q2 		$285K Sell
2,304
-1,299
-36% -$153K 0.04% 299
2020
Q1 		$348K Buy
3,603
+743
+26% +$71.7K 0.07% 209
2019
Q4 		$265K Sell
2,860
-45
-2% -$3.78K 0.05% 266
2019
Q3 		$223K Sell
2,905
-518
-15% -$45.3K 0.04% 295
2019
Q2 		$294K Hold
3,423
– – 0.06% 243
2019
Q1 		$202K Buy
+3,423
New +$197K 0.04% 345

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Caprock Group's RGEN Position: Q1 2022 in Review

Caprock Group sold out of Repligen (RGEN) in Q1 2022, closing a stake of 1,120 shares — an estimated $297K sold.

Caprock Group first reported a position in RGEN in Q1 2019 and held it in 12 quarters. The position peaked at $371K in Q3 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

  • Caprock Group reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
  • Caprock Group sold 1,120 Repligen shares in Q1 2022, an estimated $297K.
  • Caprock Group first reported a position in Repligen in Q1 2019 and held it in 12 quarters.
  • Caprock Group's Repligen position peaked at $371K in Q3 2021.
  • 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on Caprock Group's 13F filing for Q1 2022, filed 12 Apr 2022.